308 related articles for article (PubMed ID: 34352044)
21. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
Yoo L; Speck SH
J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
[TBL] [Abstract][Full Text] [Related]
22. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
Tierney RJ; Kao KY; Nagra JK; Rickinson AB
J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
[TBL] [Abstract][Full Text] [Related]
24. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
25. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
27. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
28. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.
Yoo LI; Mooney M; Puglielli MT; Speck SH
J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570
[TBL] [Abstract][Full Text] [Related]
29. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.
Glaser LV; Rieger S; Thumann S; Beer S; Kuklik-Roos C; Martin DE; Maier KC; Harth-Hertle ML; Grüning B; Backofen R; Krebs S; Blum H; Zimmer R; Erhard F; Kempkes B
PLoS Pathog; 2017 Oct; 13(10):e1006664. PubMed ID: 28968461
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
Fuentes-Pananá EM; Swaminathan S; Ling PD
J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
33. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity.
Rainio EM; Ahlfors H; Carter KL; Ruuska M; Matikainen S; Kieff E; Koskinen PJ
Virology; 2005 Mar; 333(2):201-6. PubMed ID: 15721354
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
35. Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
Viel KCMF; Parameswaran S; Donmez OA; Forney CR; Hass MR; Yin C; Jones SH; Prosser HK; Diouf AA; Gittens OE; Edsall LE; Chen X; Rowden H; Dunn KA; Guo R; VonHandorf A; Leong MML; Ernst K; Kaufman KM; Lawson LP; Gewurz B; Zhao B; Kottyan LC; Weirauch MT
BMC Genomics; 2024 Mar; 25(1):273. PubMed ID: 38475709
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
Chau CM; Zhang XY; McMahon SB; Lieberman PM
J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
[TBL] [Abstract][Full Text] [Related]
37. EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1.
Lu F; Chen HS; Kossenkov AV; DeWispeleare K; Won KJ; Lieberman PM
PLoS Pathog; 2016 Jan; 12(1):e1005339. PubMed ID: 26752713
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events.
Zhao B
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112815
[TBL] [Abstract][Full Text] [Related]
39. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Gunnell A; Webb HM; Wood CD; McClellan MJ; Wichaidit B; Kempkes B; Jenner RG; Osborne C; Farrell PJ; West MJ
Nucleic Acids Res; 2016 Jun; 44(10):4636-50. PubMed ID: 26883634
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
